[HTML][HTML] Optimizing omalizumab dosing in severe asthma—the exploration of therapeutic drug monitoring

JA Kroes, SW Zielhuis, AN Van der Meer… - The Journal of …, 2021 - jaci-inpractice.org
Therapeutic drug monitoring (TDM), measuring drug concentrations to adjust dosing and
optimize treatment outcomes, is commonly applied to personalize costly biological treatment …

Patient-reported outcome measures after 8 weeks of mepolizumab treatment and long-term outcomes in patients with severe asthma: an observational study

JA Kroes, SW Zielhuis, AN Van der Meer… - International journal of …, 2021 - Springer
Background The novel anti-IL-5 drug mepolizumab improves asthma outcomes in the
majority but not all patients with severe eosinophilic asthma. Currently it is difficult to predict …

Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report

JA Kroes, SW Zielhuis, C Bethlehem… - European Journal of …, 2022 - ejhp.bmj.com
A patient with severe asthma on benralizumab therapy was admitted to the intensive care
unit (ICU) for a coronavirus disease 2019 (COVID-19) infection. At the end of the 8 week …

[CITATION][C] Lanthanide bearing radioactive particles for cancer therapy and multimodality imaging

SW Zielhuis - 2006 - Utrecht University